The announcement comes as part of WHO’s broader effort to reduce child mortality, particularly in low- and middle-income ...

The World Health Organisation (WHO) has published its first-ever position paper on immunisation products to protect infants ...

Coronavirus and RSV are common causes of respiratory illness in the fall and winter, but you can get them any time of year. Learn more about similarities and differences in symptoms, prevention ...

Today, the World Health Organization (WHO) published its first-ever position paper on immunization products to protect ...

in advancing our understanding of RSV pathophysiology and evaluating therapeutic and preventive drugs. The study revealed that RSV efficiently infected the iPS cell-derived respiratory organoids ...

Respiratory syncytial virus (RSV) causes infections of the breathing passages and lungs. It's so common that most children have been infected with the virus by age 2, according to the Mayo Clinic.

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

RSV causes infections of the lungs and respiratory tract. It's common in children, but it can also infect adults. "A very common disease, the most common reason why a child under 5 ends up in the ...

"Inhalon’s inhaled antibody treatment approach not only targets the underlying pathophysiology of RSV and other respiratory infections, but also provides painless, self-administration by ...

RSV, which typically causes cold-like symptoms, is a leading cause of pneumonia and death in babies and older adults. The virus leads to 177,000 hospitalizations and 14,000 deaths annually in the ...